Along with many congrats, people have been asking, "what does BTD/RMAT mean?" Read on, for a terrific blog post from our CEO Greg Kunst: https://lnkd.in/gfq8jMBK
Aurion Biotech
Biotechnology
Seattle, WA 4,101 followers
We're on a mission to cure blindness with our transformational platform of advanced therapies
About us
Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care.
- Website
-
https://aurionbiotech.com
External link for Aurion Biotech
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Seattle, WA
- Type
- Privately Held
- Founded
- 2021
Locations
-
Primary
Get directions
Seattle, WA 98110, US
-
Get directions
Boston, MA, US
Employees at Aurion Biotech
-
Greg Kunst
Chief Executive Officer | Board Director | EY Entrepreneur of the Year Winner | Puget Sound Business Journal Healthcare Leadership Award Recipient |…
-
Sterling Chung
Vice President, Regulatory Affairs and Quality
-
Wendy Bliss
Associate Director of Quality Assurance at Aurion Biotech
-
Jeremiah Magers, CQA
Product Quality Leader
Updates
-
Delighted that FDA has granted both BTD and RMAT! A win for patients, since it will facilitate our development pathway! https://lnkd.in/gTuY23Ep
Aurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001 - Aurion Biotech
https://aurionbiotech.com
-
So, THIS happened! Congrats to our fab CEO, Greg Kunst! #EOYUS #EOYMTNWEST
-
Glad that our CEO Greg Kunst will be speaking at Octane's upcoming Ophthalmology Tech Forum in lovely Newport Beach CA, June 20-21. #OTF2024 #OphthalmicInnovation #OphthalmicTech
-
-
Thanks to Aurion's Nysha Blender, OD, PhD for a fantastic job presenting at ARVO this week in Seattle!
-
-
Big milestone: we've completed enrollment in our CLARA trial! https://lnkd.in/gYn-3C-N
Aurion Biotech Announces Completion of Enrollment In Phase 1 / 2 Clinical Trial - Aurion Biotech
https://aurionbiotech.com
-
Thanks to Ophthalmology Times for this terrific post of Eris Jordan, OD describing progress Aurion Biotech! https://lnkd.in/gcFzd-2f
ASCRS 2024: International data are forthcoming in corneal endothelial disease treatment
ophthalmologytimes.com
-
Delighted and honored that our CEO Greg Kunst a finalist for Entrepreneur of the Year! https://lnkd.in/g2TRCNjE
EY Announces Entrepreneur Of The Year® 2024 Mountain West Award Finalists
ey.com
-
Eris Jordan does a fantastic job interviewing Dr. Elizabeth Yeu about incredibly interesting case: cataract procedure + corneal endothelial cell therapy. terrific discussion: https://lnkd.in/gfV7ScEH
VIDEO: Corneal endothelial cell therapy trial on track to complete enrollment
healio.com